2021.09.30

Information on the stock exchange trading

Please be advised that procedures connected with admission of Bioceltix S.A. shares to stock exchange trading are currently being finalized. ... More
2021.09.10

Economic Forum in Karpacz

Łukasz Bzdzion, President of the Management Board, participated in the XXX Economic Forum in Karpacz on behalf of Bioceltix. The second day of ... More
2021.05.25

Bioceltix begins the next phase of research

We made the next important step on the way to the registration of our drug candidates in the European Medicines Agency. The next phase of ... More
2021.05.11

Increasing the company’s share capital

In connection with the issue of series G shares, on April 23, 2021, an increase in the share capital was registered. All formalities related to ... More
2021.03.10

Dom Maklerski Banku Ochrony Środowiska S.A.

We would like to inform you that Dom Maklerski Banku Ochrony Środowiska S.A. has joined the group of consortium members accepting subscriptions ... More
2021.03.04

Puls Biznesu investor chat

On 02/03/2021 there was an investor chat with our participation. We invite you to watch the chat here: ... More
2021.02.23

Puls Biznesu

Puls Biznesu about our plans: Bioceltix announces that it will soon debut on NewConnect – the company has recently completed the pre-IPO ... More
2021.02.22

Forbes- Incredibles

Forbes about Polish start-ups in the coronavirus crisis: “The year 2020 was a big challenge for companies, individual sectors of the ... More
2021.01.29

Investors’ Zone

According to the „Investors’ Zone”, an interesting year is being prepared on the stock exchange: “This year, an exceptionally large ... More
2021.01.27

Portal Wrocław

Gazeta Wrocławska wrote about us: “Bioceltix is ​​working on innovative biological medicines used in the treatment of common autoimmune and ... More